The US Treasury Department has proposed new restrictions to ban American investments in Chinese biotechnology, artificial intelligence, and advanced memory chip sectors. This move aims to limit technology transfer and could significantly impact the pharmaceutical industry by cutting off a key source of new drug development. If these bans are adopted, they may reshape investment flows and slow collaboration between US companies and Chinese biotech firms. The proposal reflects growing US concerns over technology and national security risks associated with China.
U.S. Treasury's proposed restrictions on Chinese biotech and AI come as a backdrop to a mixed day in the health sector on Pluang. For readers following health stocks, here is Pluang's market snapshot as of Oct 23, 2026 14:31 WIB: out of 150 priced health-sector US stocks, 63 rose and 85 fell. Notable movers include ENVB at USD 1.45 with a -3.97% change and 100% buy order activity, GMED at USD 81.57 up 3.67%, and NTRA at USD 398.34 down 3.64%.
BDR Pharmaceuticals has filed a lawsuit against the FDA, disputing the agency's refusal to accept an abbreviated new drug application referencing Phathom Pharmaceuticals' VOQUEZNA. BDR claims the FDA wrongly extended Phathom's exclusivity period unde...
Ipsos achieved 2.0% organic revenue growth in Q3 2026, up from 0.8% in H1, driven by strong performances in EMEA, China, and citizen-related activities. The company updated its 2026 organic growth target to 1.2%-1.5%, reflecting improved momentum and...
Ipsos posted €636.2 million revenue in Q3 2026 with 2.0% organic growth, up from 0.8% in H1, led by strong performances in EMEA, China, and its Citizens business. The company updated its full-year organic growth outlook to 1.2%-1.5%, citing ongoing g...
Signify reported third-quarter 2026 results with sales of EUR 1,367 million, a slight decline in comparable sales by 3.4%, but improved adjusted EBITA of EUR 145 million and a margin increase to 10.6%. Net income rose to EUR 88 million and free cash ...
Dogecoin (DOGE) traded at $0.0799 on October 23, showing a slight increase of 0.58% over 24 hours and staying just below the $0.08 mark. An earlier forecast from October 21 predicted DOGE would reach $0.083 by October 31, within a range of $0.072 to ...
